Description
| Glimepride, Pioglitazone And Metformin Hydrochloride (SR) Tablets IP | Each Uncoated bilayered Tablet Contains: | |||||||
| Glimepride | IP | 1 | mg | |||||
| Pioglitazone Hydrochloride Equivalent to Pioglitazone | IP | 15 | mg | |||||
| Metformin Hydrochloride (As sustained release form) | IP | 500 | mg | |||||
| Excipients | q.s. | |||||||
| Colour : Approved colour(s) used | ||||||||
| Glimepride, Pioglitazone And Metformin Hydrochloride (SR) Tablets IP | Each Uncoated bilayered Tablet Contains: | |||||||
| Glimepride | IP | 2 | mg | |||||
| Pioglitazone Hydrochloride Equivalent to Pioglitazone | IP | 15 | mg | |||||
| Metformin Hydrochloride (As sustained release form) | IP | 500 | mg | |||||
| Excipients | q.s. | |||||||
| Colour : Approved colour(s) used | ||||||||
